ClinicalTrials.govpublic full text
International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC
locally advanced or metastatic urothelial cancer, urothelial cancer, pembrolizumab, enfortumab vedotin, rare genitourinary tumors, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840326
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.